The global market for COVID-19 saliva sampling tests is projected to grow from USD 3,671.4 million in 2024 to USD 5,382.5 million by 2034, according to the latest industry analysis. This marks a steady compound annual growth rate (CAGR) of 3.9% over the forecast period. In 2023, the market recorded a revenue of USD 3,533.6 …
Category Archives: Healthcare Trends
Global Edward’s Syndrome Treatment Market to Reach USD 7.98 Billion by 2033, Driven by Advancements in Research and Diagnostic Technologies | FMI
The global edward’s syndrome treatment market is poised for significant growth, with a projected market value of USD 7.98 billion by 2033, up from USD 4.9 billion in 2023. This represents a compound annual growth rate (CAGR) of 5% during the forecast period from 2023 to 2033, according to new market insights. Edward’s syndrome, or …
Global Eosinophilic Granulomatosis with Polyangiitis Treatment Market Set for Remarkable Growth, Reaching USD 288.5 Million by 2033
The global eosinophilic granulomatosis with polyangiitis treatment market is on the cusp of significant expansion, according to recent market analysis. The market, which was valued at USD 173.8 million in 2023, is projected to grow at a Compound Annual Growth Rate (CAGR) of 5.2%, reaching an impressive USD 288.5 million by 2033. Several key factors …
Global Drug Eruptions Treatment Market to reach USD 7.1 billion by 2033, Antihistamines to account for 41% of all Treatments: FMI Study
The global drug eruptions market is estimated to be valued USD 3.89 billion in fiscal year 2023, compared to USD 3.66 billion in fiscal year 2022. The global market is anticipated to increase steadily from 2023 to 2033 at a 6.2% CAGR, reaching USD 7.1 billion by the end of that year. Skin sensitivity to …
Global Oncology-Based In-Vivo CRO Market Set for Explosive Growth, Projected to Reach USD 2.9 Billion by 2033 at a CAGR of 10.9%
The global oncology-based in-vivo CRO market is on the brink of remarkable expansion, driven by a growing demand for advanced cancer research and innovative treatment development. Recent market projections reveal that the sector, valued at USD 1.1 billion in 2023, is expected to reach an impressive USD 2.9 billion by 2033. This growth trajectory represents …
Global Cytokine Release Syndrome Management Market Poised for Growth, Expected to Reach USD 44.6 Billion by 2033
The global cytokine release syndrome management market is on track for substantial growth, with an estimated value of USD 23.32 billion in 2023. The market is projected to expand at a compound annual growth rate (CAGR) of 6.7% from 2023 to 2033, reaching an anticipated USD 44.6 billion by 2033. This growth is primarily driven …
Global Chronic Refractory Cough Treatment Market to Reach USD 17.1 Billion by 2033, driven by a 6.39% CAGR | FMI
The global chronic refractory cough treatment market is set to experience significant growth over the next decade. According to recent market analysis by FMI, the market is projected to grow from USD 9.2 billion in 2023 to an impressive USD 17.1 billion by 2033. This growth represents a robust Compound Annual Growth Rate (CAGR) of …
Global Dengue Fever Treatment Market Set for Explosive Growth, Projected to Reach USD 5435.25 Million by 2033 registering a CAGR of 20%
The global dengue fever treatment market is on the cusp of extraordinary expansion, with market value expected to soar from USD 877.82 million in 2023 to a staggering USD 5435.25 million by 2033. This remarkable growth trajectory, marked by a compound annual growth rate (CAGR) of 20%, is fueled by the increasing prevalence of dengue …
Global Coxsackievirus Infections Treatment Market to Reach USD 12.1 Billion by 2033, Fueled by Technological Advancements and Growing Awareness | FMI Study
The global coxsackievirus infections treatment market is experiencing remarkable growth, valued at USD 5.5 billion in 2023 and projected to expand at a CAGR of 8.2%, reaching an estimated USD 12.1 billion by 2033. Key Growth Drivers: Several factors are propelling the expansion of this market: Rising Incidence of Coxsackievirus Infections: The increasing prevalence of …
Global Chronic Granulomatous Disease (CGD) Management Market to Reach USD 2.11 Billion by 2033, Growing at a CAGR of 4.9%
The global chronic granulomatous disease management market is set to witness significant growth, reaching a projected market value of USD 2.11 billion by 2033, up from USD 1.31 billion in 2023. This expansion represents a steady compound annual growth rate (CAGR) of 4.9% during the forecast period of 2023 to 2033. In comparison, the market …